GlassScriptPhysician profile
David D Rettedal
NPI 1285074997
$19,118.60
in general payments reported to CMS, 2019-2025
15 companies · $353 in 2025
The $353 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,934 · 2020: $2,754 · 2021: $6,733 · 2022: $2,049 · 2023: $866 · 2024: $429 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,392 · Travel and Lodging: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,391.88 |
| Travel and Lodging | $256.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $6,222.07 | 2019-2022 | |
| Conetic Solutions, INC. | $4,649.76 | 2019-2025 | |
| Medical Device Business Services, INC. | $3,939.92 | 2019-2021 | |
| Vilex LLC | $1,777.11 | 2022 | |
| Stryker Corporation | $1,006.16 | 2019-2024 | Augment Injectable, Variax, Ortholoc 2 Lapifuse |
| Depuy Synthes Sales INC. | $715.37 | 2019-2025 | Motoband, Va-Lcp |
| Rsw Medical Company, INC. | $262.28 | 2019 | |
| Integra Lifesciences Corporation | $170.07 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Ossio INC | $124.67 | 2021 | |
| Smith+Nephew, INC. | $88.22 | 2021 | |
| Linvatec Corporation | $76.97 | 2025 | Biobrace 23mm |
| Orthofix Medical, INC. | $31.88 | 2019-2025 | Accelstim |
| Sanara Medtech INC. | $22.36 | 2024 | Celleraterx |
| Si-Bone, INC. | $18.60 | 2022 | |
| Abbott Laboratories | $13.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rettedal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.